(Q38524060)

3 September 2017

The locomotor effects of MK801 in the nucleus accumbens of developing and adult rats (English)

1 reference

3 September 2017

1 reference

Frantz K

1

1 reference

PubMed ID

10193648

3 September 2017

Van Hartesveldt C

series ordinal

2

1 reference

PubMed ID

10193648

3 September 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

European Journal of Pharmacology

3 September 2017

1 reference

3 September 2017

368

1 reference

3 September 2017

2-3

1 reference

3 September 2017

125-135

1 reference

Functional development of the dorsolateral prefrontal cortex: An analysis utilizing reversible cryogenic depression

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

The behavioral effects of MK-801 injected into nucleus accumbens and caudate-putamen of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Differential behavioural effects of dopamine agonists in developing rats: a study of 3-PPP enantiomers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Wall climbing, odors from the home nest and catecholaminergic activity in rat pups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Myelination of cortical-hippocampal relays during late adolescence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

MK-801 produces a reduction in anxiety-related antipredator defensiveness in male and female rats and a gender-dependent increase in locomotor behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Individual differences in behavioral measures: Correlations with nucleus accumbens dopamine measured by microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Ontogeny of Adrenergic Arousal and Cholinergic Inhibitory Mechanisms in the Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Ontogenetic development of kainate neurotoxicity: correlates with glutamatergic innervation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Effect of NMDA receptor antagonists on D1, D2 and D1/D2 mediated behaviors in intact rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Effects of excitatory amino acids on locomotor activity after bilateral microinjection into the rat nucleus accumbens: Possible dependence on dopaminergic mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Effects of non-competitive NMDA receptor antagonists on reproductive and motor behaviors in female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

The topography of MK-801-induced locomotor patterns in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

The locomotor effects of a putative dopamine D3 receptor agonist in developing rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Evidence for transient perinatal glutamatergic innervation of globus pallidus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

The phencyclidine-glutamate model of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Stimulatory effect of N-methyl aspartate on locomotor activity and transmitter release from rat nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Sex differences in NMDA receptor mediated responses in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Mesocorticolimbic dopaminergic network: functional and regulatory roles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Differential behavioral effects following microinjection of an NMDA antagonist into nucleus accumbens subregions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Neuropharmacological evidence to suggest that the nucleus accumbens and subpallidal region contribute to exploratory locomotion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Effects of administration of dopamine D2 agonist quinpirole on exploratory locomotion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Quinpirole to the accumbens reduces exploratory and amphetamine-elicited locomotion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Phencyclidine- and Dizocilpine-Induced Hyperlocomotion Are Differentially Mediated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Glutamate receptor dysfunction and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

In vivo demonstration of the enhancement of MK-801 by L-glutamate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Psychopharmacological effects of MK-801 in infant and preweanling rat pups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

The involvement of nucleus accumbens dopamine in appetitive and aversive motivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

The behavioral neurochemistry of motivation: methodological and conceptual issues in studies of the dynamic activity of nucleus accumbens dopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Psychopharmacological effects of low and high doses of apomorphine during ontogeny

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Periadolescence: Age‐dependent behavior and psychopharmacological responsivity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Facilitation of dopamine D1 receptor- but not dopamine D1/D2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Regional profile of developmental changes in the sensitivity of the N-methyl-D-aspartate receptor to polyamines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Injection of the competitive NMDA receptor antagonist AP-5 into the nucleus accumbens of monoamine-depleted mice induces pronounced locomotor stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Interaction between glutamatergic and dopaminergic tone in the nucleus accumbens of mice: evidence for a dual glutamatergic function with respect to psychomotor control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Glutamatergic neurons projecting to the nucleus accumbens can affect motor functions in opposite directions depending on the dopaminergic tone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Temporal and environmental effects on quinpirole-induced biphasic locomotion in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Effects of intracerebral quinpirole on locomotion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Ontogeny of biphasic locomotor effects of quinpirole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Effects of caudate nuclei or frontal cortical ablations in cats. I. Neurology and gross behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Developmentally moderated expressions of the neuropathology underlying schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Chronic mild stress-induced anhedonia: a realistic animal model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Differential effects of quinpirole in the nucleus accumbens depending on the initial level of locomotor activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Functional interaction of dopamine and glutamate in the nucleus accumbens in the regulation of locomotion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

Differential ontogeny of working memory and reference memory in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900009-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(99)00009-6

1 reference

3 September 2017

1 reference

PubMed ID

10193648